An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network - December 16-17, 2021

Maria G. Isaguliants; Ivan Trotsenko; Franco M. Buonaguro

doi:10.1186/s13027-022-00436-0

An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network - December 16-17, 2021

Maria G. Isaguliants (Corresponding Author)
, Ivan Trotsenko
, Franco M. Buonaguro (Corresponding Author)

Rīga Stradiņš University

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined at the symposium “Chronic viral infection and cancer, openings for vaccines” virtually held on December 16–17, 2021. Experts from the various disciplines involved in the study of the complex relationships between solid tumors and viruses met to discuss recent developments in the field and to report their personal contributions to the specified topics. Secondary end point was to sustain the TECHVAC Network established in 2016 as a multidisciplinary work group specifically devoted to development of vaccines and immunotherapies against chronic viral infections and associated cancers, with the aim to identify areas of common interest, promote research cooperation, establish collaborative cross-border programs and projects, and to coordinate clinical and research activities.

Original language	English
Article number	28
Pages (from-to)	28
Journal	Infectious Agents and Cancer
Volume	17
Issue number	Suppl 2
DOIs	https://doi.org/10.1186/s13027-022-00436-0
Publication status	Published - Jul 2022
Event	Chronic viral infections and Cancer, openings for vaccines - Online Duration: 16 Dec 2021 → 17 Dec 2021 https://techvac.org/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Field of Science*

3.2 Clinical medicine
3.1 Basic medicine

Publication Type*

3.1. Articles or chapters in proceedings/scientific books indexed in Web of Science and/or Scopus database

Access to Document

10.1186/s13027-022-00436-0

Cite this

@article{9995445b5cb04552970ebf3a38b0ec7d,

title = "An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network - December 16-17, 2021",

abstract = "This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined at the symposium “Chronic viral infection and cancer, openings for vaccines” virtually held on December 16–17, 2021. Experts from the various disciplines involved in the study of the complex relationships between solid tumors and viruses met to discuss recent developments in the field and to report their personal contributions to the specified topics. Secondary end point was to sustain the TECHVAC Network established in 2016 as a multidisciplinary work group specifically devoted to development of vaccines and immunotherapies against chronic viral infections and associated cancers, with the aim to identify areas of common interest, promote research cooperation, establish collaborative cross-border programs and projects, and to coordinate clinical and research activities.",

author = "Isaguliants, \{Maria G.\} and Ivan Trotsenko and Buonaguro, \{Franco M.\}",

note = "Funding Information: Publication is supported by the Program NAWA EUROPARTNER: Strengthening and spreading international partnership activities of the Faculty of Biology and Environmental Protection for interdisciplinary research and innovation of the University of Lodz and Virtual Mobility Grant of the European Network of Vaccine Adjuvants ENOVA COST Action CA16231 to MGI at Riga Stradins University, Riga, Latvia. Publisher Copyright: {\textcopyright} 2022, The Author(s).; Chronic viral infections and Cancer, openings for vaccines ; Conference date: 16-12-2021 Through 17-12-2021",

year = "2022",

month = jul,

doi = "10.1186/s13027-022-00436-0",

language = "English",

volume = "17",

pages = "28",

journal = "Infectious Agents and Cancer",

issn = "1750-9378",

publisher = "BioMed Central Ltd.",

number = "Suppl 2",

url = "https://techvac.org/",

}

An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network - December 16-17, 2021. / Isaguliants, Maria G. (Corresponding Author); Trotsenko, Ivan; Buonaguro, Franco M. (Corresponding Author).
In: Infectious Agents and Cancer, Vol. 17, No. Suppl 2, 28, 07.2022, p. 28.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network - December 16-17, 2021

AU - Isaguliants, Maria G.

AU - Trotsenko, Ivan

AU - Buonaguro, Franco M.

N1 - Funding Information: Publication is supported by the Program NAWA EUROPARTNER: Strengthening and spreading international partnership activities of the Faculty of Biology and Environmental Protection for interdisciplinary research and innovation of the University of Lodz and Virtual Mobility Grant of the European Network of Vaccine Adjuvants ENOVA COST Action CA16231 to MGI at Riga Stradins University, Riga, Latvia. Publisher Copyright: © 2022, The Author(s).

PY - 2022/7

Y1 - 2022/7

N2 - This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined at the symposium “Chronic viral infection and cancer, openings for vaccines” virtually held on December 16–17, 2021. Experts from the various disciplines involved in the study of the complex relationships between solid tumors and viruses met to discuss recent developments in the field and to report their personal contributions to the specified topics. Secondary end point was to sustain the TECHVAC Network established in 2016 as a multidisciplinary work group specifically devoted to development of vaccines and immunotherapies against chronic viral infections and associated cancers, with the aim to identify areas of common interest, promote research cooperation, establish collaborative cross-border programs and projects, and to coordinate clinical and research activities.

AB - This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined at the symposium “Chronic viral infection and cancer, openings for vaccines” virtually held on December 16–17, 2021. Experts from the various disciplines involved in the study of the complex relationships between solid tumors and viruses met to discuss recent developments in the field and to report their personal contributions to the specified topics. Secondary end point was to sustain the TECHVAC Network established in 2016 as a multidisciplinary work group specifically devoted to development of vaccines and immunotherapies against chronic viral infections and associated cancers, with the aim to identify areas of common interest, promote research cooperation, establish collaborative cross-border programs and projects, and to coordinate clinical and research activities.

UR - https://www.scopus.com/pages/publications/85133720148

U2 - 10.1186/s13027-022-00436-0

DO - 10.1186/s13027-022-00436-0

M3 - Article

C2 - 35804391

AN - SCOPUS:85133720148

SN - 1750-9378

VL - 17

SP - 28

JO - Infectious Agents and Cancer

JF - Infectious Agents and Cancer

IS - Suppl 2

M1 - 28

T2 - Chronic viral infections and Cancer, openings for vaccines

Y2 - 16 December 2021 through 17 December 2021

ER -